Malaysia Healthcare Cardiology

Cardiology care is rising in Malaysia due to an aging population and increasing risk factors for hypertension, diabetes, high cholesterol levels, and obesity. The National Heart Institute of Malaysia reports cardiovascular diseases represent around 8% of hospitalizations, that coronary angioplasty patients average 57 years old, and that cardiovascular mortality accounted for 16.1% and 20,322 of all certified deaths in 2022.
 
Malaysia is recognized as Asia’s hub for cardiology, featuring leading centers like the National Heart Institute (IJN) and various private hospitals. The Ministry of Health (MOH) operates seven cardiothoracic centers, including Serdang Hospital’s Cardiology Centre, and six others in Penang, Johor Bahru, Kuantan, Kota Baru, Kuching, and Kota Kinabalu. These facilities offer a complete range of advanced treatments for both Malaysians and international healthcare travelers.
 
This creates a variety of opportunities for U.S. firms offering healthcare products, services, and technology. There is a shortage of cardiothoracic surgeons, driving opportunities for training and support services. Malaysia’s cardiology medical devices market is growing and is projected to reach US$525 million in 2024, as reported by the online statistics platform Statista. Malaysian healthcare providers are advancing cardiac care through quickly adopting Fourth Industrial Revolution technologies, such as Artificial Intelligence (AI) and big data, to enhance diagnostic accuracy and streamline the transfer of medical records, particularly for international patients. There is demand for solutions that increase successful outcomes. These include comprehensive health check-ups, regular heart screenings, electrocardiography, blood testing, and nutrition counseling, together with preventive cardiology, low-risk heart surgery alternatives, and drug treatments. Malaysian cardiology providers are also interested in personalized treatments tailored to patient risk profiles, ongoing training in care advancements, optimized treatment protocols, and digital health analytics for real-time monitoring and patient progress tracking.
 
If your U.S. company specializes in cardiology-related solutions and you wish to explore opportunities in the Malaysian market, please contact Commercial Specialist Bethany Tien at office.kualalumpur@trade.gov.